NYSE:ZBH - New York Stock Exchange, Inc. - US98956P1021 - Common Stock
The robotic-assisted surgery trend is accelerating and Intuitive Surgical continues to lead the pack as its continued to keeps its wide moat since 2000.
Tesla upgraded, MongoDB initiated: Wall Street's top analyst calls
Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.
/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision...
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
The company is well known for its hip and knee replacements. Full-year sales will take an unexpected hit.
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds.
The company spun out from Zimmer Biomet in 2022. Now, it's a possible takeover candidate.